Home >> Tag Archives: Rheonix—

Tag Archives: Rheonix—

Rapid Zika virus diagnostic, 6/16

June 2016—Rheonix, in collaboration with New York University College of Dentistry, has received funding from a Small Business Innovation Research Phase I/II Fast-track grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to develop a rapid diagnostic for Zika virus infection.

Read More »

Rheonix develops rapid, self-confirming HIV test

March 17, 2016—Rheonix has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood. The Rheonix system aims to improve HIV testing by detecting early, acute HIV infection and addressing the seroconversion window when antibodies are not yet detectable, thus eliminating the need ...

Read More »

RUO molecular platform, 7/15

July 2015—Rheonix showcased in June its Encompass Optimum research-use-only platform at the 115th General Meeting of the American Society for Microbiology. The Encompass Optimum is an automated system for building and implementing molecular assays as a nonclinical tool.

Read More »